BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Molinari M, De Coutere S, Krahn M, Helton S, Urbach DR. Patients' preferences and trade-offs for the treatment of early stage hepatocellular carcinoma. J Surg Res. 2014;189:57-67. [PMID: 24650457 DOI: 10.1016/j.jss.2014.02.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Ma S, Yang X, Zhou H, Zhang C, Kang J, Sun D. Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice. Onco Targets Ther 2020;13:6997-7005. [PMID: 32764990 DOI: 10.2147/OTT.S260353] [Reference Citation Analysis]
2 Burman B, Helton WS. Disparities in care for patients with curable hepatocellular carcinoma. HPB (Oxford) 2015;17:745-6. [PMID: 26278320 DOI: 10.1111/hpb.12477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Seghers PALN, Wiersma A, Festen S, Stegmann ME, Soubeyran P, Rostoft S, O'Hanlon S, Portielje JEA, Hamaker ME. Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient-A Systematic Review. Cancers (Basel) 2022;14:1147. [PMID: 35267455 DOI: 10.3390/cancers14051147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hauber B, Coulter J. Using the Threshold Technique to Elicit Patient Preferences: An Introduction to the Method and an Overview of Existing Empirical Applications. Appl Health Econ Health Policy 2020;18:31-46. [DOI: 10.1007/s40258-019-00521-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Chen LC, Lin HY, Hung SK, Chiou WY, Lee MS. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2434-2457 [PMID: 34092968 DOI: 10.3748/wjg.v27.i20.2434] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Molinari M, El-Tawil K, Swaid F, Fiorentini G, Bou-Samra P, Sharma C, Liu H, Rahman SH, Hurton S, Tsung A. Patients' treatment preferences for potentially resectable tumors of the head of the pancreas. HPB (Oxford) 2020;22:265-74. [PMID: 31501009 DOI: 10.1016/j.hpb.2019.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Chiba T, Hiraoka A, Mikami S, Shinozaki M, Osaki Y, Obu M, Ohki T, Mita N, Ledesma D, Yoshihara N, Beusterien K, Amos K, Bridges JF, Yokosuka O. Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments. Patient Prefer Adherence 2019;13:637-47. [PMID: 31118587 DOI: 10.2147/PPA.S198363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]